证券代码：300181 证券简称：佐力药业 编号：2025-013 问题三：百令系列下半年集采执行节奏及全年增长预期？ 答：百令片和百令胶囊均参与了全国中成药采购联盟集采，目 前已有 28 个省份发布集采执行通知，随着集采的推进，公司 将在更多省份完成挂网和销售工作，预计下半年集采落实执行 将进入全面铺开阶段。2025 年上半年，百令系列销售收入较 上年同期增长了 38.51%，展望全年，百令系列有望通过以价 换量的方式，进一步扩大市场份额。同时，百令胶囊作为新产 品，公司选择优质代理商快速覆盖市场，同时积极向县级医院、 基层医疗机构下沉，预计全年销售将实现显著增长。 问题四：中药饮片和中药配方颗粒业务目前市场拓展情况？ 答：中药配方颗粒目前已经完成 468 个国标和省标的备案， 浙江佐力药业股份有限公司 投资者关系活动记录表 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | 其他 （电话会议） | | 参与单位名称及 | 东吴证券；平安证券；国海证券；申万宏 ...

不难理解，作为曾经负责哪吒汽车国内市场营销的相关负责人之一，在张磊（化名）任期内的哪吒汽车历经无数"高光时刻"，不仅2022年问鼎"国内新势 力车企年度销量冠军"，风头一度盖过"蔚小理"，更成为彼时汽车、资本市场眼中的璞玉。在外界看来，这家血脉中融合了传统车企、地方国资和"清华 系"基因的新势力，完全具备"我命由我不由天"的黑马潜质。 但突然的转折也让张磊始料未及。2024年新年钟声敲响，哪吒汽车的销量最终定格在12.7万辆，仅为2023年年初定下目标的一半。很快，"销量滑坡"的责 任被分割划清，一部分员工的年终奖被打了7折，一纸职务调整公告则结束了张磊在哪吒汽车的职业生涯。面对《每日经济新闻》记者的"旧事重提"，他 笑了笑，声音多了些无奈。 曾以29亿元投资、并成为第二大股东的"红衣教主"周鸿祎（360集团创始人、董事长），用他的"流量"为哪吒汽车站台，直播、拍卖迈巴赫、吐槽高管等 话题不断涌上热搜，但最终未能拯救哪吒汽车于"水火之中"，甚至导致品牌形象进一步受损。 8月11日，中国执行信息公开网的一则因违反财产报告制度，被广州海珠区法院列为失信被执行人的公告，再次将哪吒汽车拉回公众视野。 "别问了，别问了 ...

Core Viewpoint - Zhaoli Pharmaceutical (300181.SZ) has demonstrated strong profitability with a cumulative return of 154.14% over three years, despite a generally lackluster performance in the traditional Chinese medicine sector [1] Financial Performance - The company's net profit attributable to shareholders increased from 25.59 million yuan in 2019 to 508 million yuan in 2024 [1] - The gross profit margin for Zhaoli Pharmaceutical has decreased from 71.43% in 2021 to 60.95% currently, a decline of approximately 10 percentage points [7] Key Products - Zhaoli Pharmaceutical specializes in traditional Chinese medicine products, with its flagship product, Wuling Capsule, generating 1.438 billion yuan in revenue in 2024, accounting for 55.79% of total revenue [3] - Wuling Capsule, used for treating insomnia, is a 1 billion yuan-level product with a stable gross profit margin exceeding 80% [4][5] Market Position and Competitive Advantage - Wuling Capsule benefits from unique barriers to entry, including proprietary technology and its inclusion in the National Essential Medicines List, which limits competition and maintains pricing power [3][5] - The company has successfully increased the packaging size of Wuling Capsule to enhance sales and reduce marginal costs [5] Strategic Focus - Zhaoli Pharmaceutical is committed to its core business of traditional Chinese medicine while expanding into the rapidly growing market for traditional Chinese medicine pieces and granules [11] - The company aims to develop its Bailing series products into a 1 billion yuan-level product by 2025, despite facing competition from established players [12] Sales Channels and Growth Strategy - The company is shifting its sales strategy from primarily hospital sales to a more consumer-oriented approach, targeting online retail and chain pharmacies to tap into the broader health market [13]

Core Insights - The chairman of Yuanlong Yatu, Sun Zhen, stated that the company's strategic goal for 2025 is to solidify its B-end business while leveraging the capabilities and resources accumulated from the B-end to fully enter the C-end market [1] Group 1: Business Strategy - The company is accelerating the layout of a rich online and offline channel matrix, including offline brand experience stores, airport and high-speed rail counters, pop-up stores in shopping malls, and vending machines [1] - The first "Yuanlong Yatu Cultural and Creative Life Museum" experience store has recently opened at Chengdu Shuangliu Airport T1 terminal [1] Group 2: Online and Offline Integration - The company is actively exploring and establishing a cooperative franchise system [1] - In addition to signing IP official flagship stores on mainstream e-commerce platforms and operating existing self-owned stores, the company is also deeply laying out WeChat small stores to create a new ecosystem of "social + gifts" [1] - The integration of online and offline development is laying a solid foundation for establishing and improving the Yuanlong Yatu cultural and creative e-commerce ecosystem [1]